Skip to main content

Table 5 Characteristics of longitudinal assessment

From: Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy

 

N

Mean ± SD or N (%)

CMR 1 to CMR 2

 Interval (days)

55

423 ± 200

 ∆LVEF1–2 (%)

55

− 2.6 ± 4.7

 Base ∆Ɛcc1–2

54

0.7 ± 3.0

 Mid ∆Ɛcc1–2

55

0.7 ± 3.3

 Apex ∆Ɛcc1–2

52

0.6 ± 3.4

 ∆FWHM1–2

37

4.3 ± 14.2

 ∆LGE1–2

53

 

  − 1

 

4 (8%)

  0

 

31 (58%)

  1

 

15 (28%)

  2

 

2 (4%)

  3

 

1 (2%)

CMR 2 to CMR 3

 Interval (days)

35

376 ± 26

 ∆LVEF2–3 (%)

35

− 2.4 ± 5.5

 Base ∆Ɛcc2–3

34

0.4 ± 3.1

 Mid ∆Ɛcc2–3

34

0.8 ± 3.1

 Apex ∆Ɛcc2–3

32

0.1 ± 3.8

 ∆FWHM2–3

27

3.2 ± 16.3

 ∆LGE2–3

35

 

  − 1

 

4 (11%)

  0

 

17 (49%)

  1

 

11 (31%)

  2

 

3 (9%)

CMR 1 to CMR 3

 Interval (days)

35

748 ± 344

 ∆LVEF1–3 (%)

35

− 5.1 ± 5.8

 Base ∆Ɛcc1–3

35

1.2 ± 3.2

 Mid ∆Ɛcc1–3

34

1.3 ± 3.4

 Apex ∆Ɛcc1–3

34

0.7 ± 4.1

 ∆FWHM1–3

23

9.0 ± 16.6

 ∆LGE1–3

35

 

  − 1

 

2 (6%)

  0

 

15 (43%)

  1

 

13 (37%)

  2

 

2 (6%)

  3

 

3 (9%)